REDMILE GROUP other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}

Adviser Profile

As of Date:

07/03/2024

Adviser Type:

- Large advisory firm


Number of Employees:

35 -7.89%

of those in investment advisory functions:

20


Registration:

SEC, Approved, 4/19/2007

AUM:

6,473,965,022 -10.54%

of that, discretionary:

6,473,965,022 -10.54%

Private Fund GAV:

7,202,682,127 -6.75%

Avg Account Size:

239,776,482 -10.54%


SMA’s:

NO

Private Funds:

18

Contact Info

415 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
14B 12B 10B 8B 6B 4B 2B
2015 2016 2017 2018 2019 2020 2021 2022 2023

Recent News

Redmile Group, LLC Boosts Stake in Neoleukin Therapeutics Inc
07/28/2023

Related Stocks: NLTX, FOLD, ISEE, KRYS, DCPH, AKRO,

gurufocus.com

Redmile Group, LLC Reduces Stake in IGM Biosciences Inc
07/10/2023

Related Stocks: IGMS, FOLD, ISEE, KRYS, DCPH, AKRO,

gurufocus.com

Redmile Group, LLC Reduces Stake in IGM Biosciences Inc
07/10/2023

Related Stocks: IGMS, FOLD, ISEE, KRYS, DCPH, AKRO,

gurufocus.com

Redmile Group, LLC Buys Adagio Therapeutics Inc, Absci Corp, LivaNova PLC, Sells DexCom Inc, ...
11/16/2021

Related Stocks: LIVN, UNH, GRTS, ADGI, ABSI, SLGC, STVN, ZGNX, DXCM, ZY, SLQT, CRL, CI, CTLT,

gurufocus.com

Redmile Group, LLC Buys Verve Therapeutics Inc, The Beauty Health Co, Nurix Therapeutics Inc, ...
08/24/2021

Related Stocks: ONEM, SLQT, VERV, SKIN, NRIX, ZY, ALXO, LFST, MDT, GNMK, BIIB, VSPR, QURE, DVAX,

gurufocus.com

Redmile Group, LLC Buys Jazz Pharmaceuticals PLC, Seagen Inc, Medtronic PLC, Sells AbbVie Inc, ...
06/24/2021

Related Stocks: KRYS, TCRR, CLDX, VSPR, ITMR, JAZZ, SGEN, MDT, ANNX, LIVN, N,

gurufocus.com


Private Funds Structure

Fund Type Count GAV
Hedge Fund 8 $4,525,974,872
Private Equity Fund 3 $1,198,399,193
Venture Capital Fund 7 $1,478,308,062

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM # funds
MANCHESTER CAPITAL MANAGEMENT LLC 336.1m - 41.4m - - 99.6m 25.5m 602.3m 3.7b 15
GALVANIZE CLIMATE SOLUTIONS LLC 57.4m - 980.9m 116.0m - 27.1m - 1.2b 1.2b 6
RICE PARK CAPITAL 683.7m - 152.8m - - 12.9m - 862.3m 891.2m 4
CBF ADVISORS, LLC 41.4m - - - - 45.5m - 132.4m 41.4m 2
CERCANO MANAGEMENT LLC 4.1b - 790.5m - - 1.1b 3.8b 10.9b 10.5b 28
EXIGENT MANAGEMENT LTD. 17.3m - 7.4m - - 62.4m - 149.4m - 11
SALUDA GRADE ASSET MANAGEMENT LLC 2.5b - 45.0m - - 58.6m - 2.7b 2.6b 6
CRAIG DRILL CAPITAL CORPORATION 46.5m - 17.3m - - 5.1m - 73.9m - 4
ASSET MANAGEMENT GROUP INVESTMENT CORP. 74.4m - 10.7m - - 104.4m - 293.9m 189.5m 19
AVORO CAPITAL ADVISORS LLC 8.6b - - - - 165.8m - 8.9b 8.7b 2

Private Funds



Employees




Brochure Summary

Overview

Description of Advisory Firm. For the purposes of this brochure, the “Firm” means Redmile Group, LLC, a Delaware limited liability company, together (where the context permits) with its affiliated general partners of the Funds (each, a “General Partner”) and other affiliates that provide advisory services to and/or receive advisory fees from the Funds. Such affiliates are under common control with Redmile Group, LLC and possess a substantial identity of personnel and/or equity owners with Redmile Group, LLC. These affiliates may be formed for tax, regulatory or other purposes in connection with the organization of the Funds, or may serve as general partners of the Funds. The Firm was formed in March 2007 and became operational shortly thereafter. Jeremy Green is the managing member and principal owner of the Firm. The Firm generally provides investment management, advisory and sub-advisory services to investment vehicles that are exempt from registration under the Investment Company Act of 1940, as amended (together with any special purpose vehicles (“SPVs”) and other investment vehicles and accounts advised by the Firm, the “Funds”), focusing primarily on making investments in U.S. and non-U.S. healthcare companies. In limited circumstances, the Firm also provides certain consulting services. The Firm provides investment management and advisory services to open-end funds that invest primarily in public equities, closed-end venture capital or growth equity funds and closed-end funds that invest primarily in public equities. The firm also provides investment management and advisory services to certain SPVs which typically are structured to implement a specific trade thesis or to invest in and around a specific company. Certain open-ended Funds previously designated securities for which there was no ready market as “Designated Investments,” although the Firm has discontinued accepting new capital for participation in Designated Investments and does not intend to enter into any new Designated
Investments (aside from follow-on investments in existing Designated Investments). Certain other investments that are reasonably deemed by the Firm to either exceed a Fund’s concentration or risk parameters then in effect or be subject to legal, contractual or other restrictions are designated as “Special Investments.” The Firm’s authority with respect to Special Investments only applies to then existing public positions that it reasonably expects to be able to exit within three to 12 months. The Firm provides investment supervisory services to each Fund in accordance with the limited partnership agreement (or analogous organizational document) of such Fund or separate investment and advisory, investment management or portfolio management agreements (each, an “Advisory Agreement”). Investment advice is provided directly to the Funds, subject to the discretion and control of the applicable General Partner and not individually to the investors in the Funds. Services are provided to the Funds in accordance with the Advisory Agreements with the Funds and/or organizational documents of the applicable Funds. Investment restrictions for the Funds, if any, are generally established in the organizational or offering documents of the applicable Funds, Advisory Agreements and/or side letter agreements negotiated with investors in the applicable Funds (such documents collectively, a Fund’s “Organizational Documents”). Description of Advisory Services. The Firm manages the portfolios of the Funds on a discretionary basis according to the investment objectives and restrictions of each Funds. The investment objective and strategy for each Fund is described in more detail in its Organizational Documents. Wrap Fee Programs. The Firm does not participate in wrap fee programs. Assets Under Management. As of December 31, 2023, the Firm had approximately $6.474 billion in client net assets under management on a discretionary basis. The Firm currently does not manage assets on a non-discretionary basis.